Kanade Shinkai, MD


Dr. Kanade Shinkai is an attending physician in the Dermatology Clinic. She has expertise in dermatology of hospitalized, systemically ill patients. She sees patients with all types of skin disease but specializes in complex medical dermatology with a focus on autoimmune and autoinflammatory disorders of skin. Shinkai performs research on immunologic and inflammatory cutaneous diseases.


Dermatology Clinic
1701 Divisadero St., Third and Fourth Floors
San Francisco, CA 94115
Phone: (415) 353–7800
Fax: (415) 353–7870

Hours: Monday to Friday, 8 a.m. – 5 p.m.

PCOS Clinic
499 Illinois St.
San Francisco, CA 94158
Phone: (415) 885-3674
Fax: (415) 353-7744

Hours: Two Thursdays a month
8 a.m. – 5 p.m.

Board Certification

Dermatology, American Board of Dermatology

Academic Title

Associate Professor

More about Kanade Shinkai


UCSF School of Medicine 2004


UCSF Medical Center, Dermatology 2008

Selected Research and Publications

  1. Saeed L, Schmidt TH, Gensler LS, Gross AJ, Fox LP, Scharschmidt TC, Gaensler K, Naik H, Rosenblum MA, Shinkai K. Successful treatment of mucous membrane pemphigoid with bortezomib. JAAD Case Rep. 2018 Jan; 4(1):81-83.
  2. Shinkai K, Chen CA, Schwartz BS, Loeser H, Ashe C, Irby DM. Rethinking the Educator Portfolio: An Innovative Criteria-Based Model. Acad Med. 2017 Nov 07.
  3. Kushner T, Shinkai K, Fox L, Ying D, Gross A, Balitzer D, Gill R, Brandman D. New Presentation of Autoimmune Hepatitis with Erythema Multiforme. Hepatology. 2017 Oct 23.
  4. Gantz M, Butler D, Goldberg M, Ryu J, McCalmont T, Shinkai K. Atypical features and systemic associations in extensive cases of Grover disease: A systematic review. J Am Acad Dermatol. 2017 Sep 14.
  5. Chen A, Shinkai K. Important Considerations for Diversity in the Selection of Dermatology Applicants. JAMA Dermatol. 2017 Sep 01; 153(9):949.
  6. Abrouk M, Farahnik B, Zhu TH, Nakamura M, Singh R, Lee K, Lucking SM, Blossom J, Liao W, Koo J, Bhutani T, Shinkai K, Nguyen T. Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses. J Am Acad Dermatol. 2017 07; 77(1):177-180.
  7. Schmidt TH, Okhovat JP, Khanijow K, Huddleston H, Cedars M, Pasch L, Wang ET, Lee J, Shinkai K. Rotterdam criteria-based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study. J Am Acad Dermatol. 2017 07; 77(1):174-176.
  8. Chen CA, Shinkai K. Increasing Diversity in Dermatology Residencies-Reply. JAMA Dermatol. 2017 Jul 01; 153(7):728-729.
  9. Walsh RK, Endicott AA, Shinkai K. Diagnosis and Treatment of Rosacea Fulminans: A Comprehensive Review. Am J Clin Dermatol. 2017 Jun 27.
  10. Maverakis E, Wang EA, Shinkai K, Mahasirimongkol S, Margolis DJ, Avigan M, Chung WH, Goldman J, La Grenade L, Pirmohamed M, Shear NH, Tassaeeyakul W, Hoetzenecker W, Klaewsongkram J, Rerkpattanapipat T, Manuyakorn W, Yasuda SU, Sharon VR, Sukhov A, Micheletti R, Struewing J, French LE, Cheng MY. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group. JAMA Dermatol. 2017 Jun 01; 153(6):587-592.
  11. Granstein RD, Cornelius L, Shinkai K. Diversity in Dermatology-A Call for Action. JAMA Dermatol. 2017 Jun 01; 153(6):499-500.
  12. Reid SP, Kao CN, Pasch L, Shinkai K, Cedars MI, Huddleston HG. Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study. Fertil Res Pract. 2017; 3:8.
  13. Trivedi MK, Shinkai K, Murase JE. A Review of hormone-based therapies to treat adult acne vulgaris in women. Int J Womens Dermatol. 2017 Mar; 3(1):44-52.
  14. West ES, Shinkai K, Ai WZ, Pincus LB. Remission of subcutaneous panniculitis-like T-cell lymphoma in a pregnant woman after treatment with oral corticosteroids as monotherapy. JAAD Case Rep. 2017 Mar; 3(2):87-89.
  15. Afifi L, Saeed L, Pasch LA, Huddleston HG, Cedars MI, Zane LT, Shinkai K. Association of ethnicity, Fitzpatrick skin type, and hirsutism: A retrospective cross-sectional study of women with polycystic ovarian syndrome. Int J Womens Dermatol. 2017 Mar; 3(1):37-43.
  16. Chen A, Shinkai K. Rethinking How We Select Dermatology Applicants-Turning the Tide. JAMA Dermatol. 2017 Mar 01; 153(3):259-260.
  17. Afifi L, Shinkai K. Communication strategies for a successful inpatient dermatology consultative service: a narrative review. Semin Cutan Med Surg. 2017 Mar; 36(1):23-27.
  18. Afifi L, Shinkai K. Optimizing education on the inpatient dermatology consultative service. Semin Cutan Med Surg. 2017 Mar; 36(1):28-34.
  19. Quinn MM, Kao CN, Ahmad A, Lenhart N, Shinkai K, Cedars MI, Huddleston HG. Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk. Fertil Steril. 2016 Oct; 106(5):1244-1251.
  20. Pasch L, He SY, Huddleston H, Cedars MI, Beshay A, Zane LT, Shinkai K. Clinician vs Self-ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome: Associations With Quality of Life and Depression. JAMA Dermatol. 2016 Jul 01; 152(7):783-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.